Y Intercept (Hong Kong) LTD Eton Pharmaceuticals, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 10,991 shares of ETON stock, worth $154,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,991
Previous 13,400
17.98%
Holding current value
$154,093
Previous $173,000
9.83%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ETON
# of Institutions
88Shares Held
14.1MCall Options Held
61.2KPut Options Held
33.1K-
Opaleye Management Inc. Boston, MA2.85MShares$40 Million10.18% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.94MShares$27.2 Million1.98% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$16.5 Million0.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$15.4 Million0.0% of portfolio
-
Cannell Capital LLC Alta, WY691KShares$9.69 Million3.17% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $355M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...